8-K/AExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K/A Report, Exhibit Filing (Nov 6, 2014)

Filed November 6, 2014For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) filed an 8-K/A amendment on November 5, 2014, to provide updated information regarding its financial statements and exhibits, specifically relating to pro forma financial information. While the filing itself is brief and directs readers to "See" for the pro forma data, it indicates a significant ongoing or previously reported event that requires this financial disclosure. Investors should look to the referenced "See" section, presumably within the original filing or an accompanying document, to understand the context and financial implications of this pro forma information. The amendment suggests that the company is refining or supplementing its financial reporting related to a material event. Given that this is an amendment (8-K/A) and the event date is February 2, 2014, it is likely related to a past acquisition, divestiture, or significant restructuring. The focus on pro forma financial information means investors should be evaluating the potential combined or adjusted financial performance of the company as if a specific event had occurred at an earlier point in time. This allows for a more standardized comparison of financial results over different periods. Investors are encouraged to consult the full original filing and any referenced documents to fully grasp the nature of the transaction and its projected financial impact on Thermo Fisher Scientific.

Key Highlights

  • 1Thermo Fisher Scientific Inc. (TMO) filed an 8-K/A amendment on November 5, 2014.
  • 2The amendment pertains to Item 9.01: Financial Statements and Exhibits.
  • 3Specifically, the filing addresses Pro Forma Financial Information.
  • 4The event date referenced for the underlying disclosure is February 2, 2014.
  • 5The filing indicates that the detailed pro forma financial information is available by referencing "See".
  • 6This suggests an update or supplement to previously filed financial data concerning a material event.
  • 7Investors should review the full original filing and referenced documents for comprehensive details.

Frequently Asked Questions

The primary purpose of this 8-K/A filing is to amend or supplement previously filed information concerning financial statements and exhibits, specifically focusing on the presentation of Pro Forma Financial Information for Thermo Fisher Scientific Inc.

Pro Forma Financial Information presents financial data that has been adjusted to show how a company might have performed if a particular event, such as an acquisition or divestiture, had occurred at an earlier date. It helps in comparing financial results more meaningfully over time, especially after significant corporate actions.

Given the amendment nature of the filing and the event date of February 2, 2014, the pro forma information likely relates to a significant transaction (e.g., acquisition, merger, or divestiture) that occurred around that time. Investors need to refer to the original filing or referenced documents for the specific details of the transaction.

This 8-K/A filing itself directs investors to "See" for the pro forma financial information. This typically means the actual pro forma statements are included in an exhibit to the original 8-K filing or within a linked document referenced in the filing. Investors should consult the full original SEC filing for Thermo Fisher Scientific Inc. dated around the event date.